AI주식인사이트AI Stock Insight
B

유나이티드제약

033270KOSPI의약품 제조업

59.8 / 100

Reference Date: 2026-07-24

Financial Score28.0 / 40
News Sentiment15.8 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but Operating Profit is on a declining trend. Slightly up 1.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

United Pharmaceutical is a specialized generic drug manufacturer focusing on improved drugs, achieving sales of 2.887 trillion won in 2024 with a 20% operating profit margin through key products like Silostan CR Tablets and Artmax Combi Gel. The company maintains advanced production facilities and R&D capabilities, exporting pharmaceuticals to over 40 countries and launching 17 improved drug formulations.

Number of Employees

902people

Average Salary

67.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
6.66Industry Average 11.236.5Point

Lower than industry avg (good)

PBR
0.61Industry Average 0.814.0Point

In line with industry avg

ROE
8.90Industry Average 4.017.0Point

2.2x industry avg (excellent)

Debt Ratio
3.76Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲1.8% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼4.7% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 10.2% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 1Neutral 2Negative 0Average Sentiment Score 63.3

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 17,410Won52-week high 21,85052-week low 16,600
1-month return3.0Point

1m 1.63% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0
  • Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-10
  • Neutral임원ㆍ주요주주특정증권등거래계획보고서2026-07-10
  • Neutral[기재정정]임원ㆍ주요주주특정증권등소유상황보고서2026-07-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-08
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-08